CASMED's Fore-Sight Cerebral Oximeter Approved In China

CAS Medical Systems (CASMED) has reported that its Fore-Sight cerebral oximeter has been approved by the Chinese State FDA for sale in the country. Fore-Sight is the only cerebral oximeter manufactured outside of China to have approval from the State FDA.

According to a report by iData Research, a number of factors are contributing to increased cardiovascular surgery in China, including the growth of the overall economy, greater public access to medical professionals and hospitals and a rise in Western diets; the latter is leading to a specific increase in coronary artery bypass graft procedures. Accordingly, the demand for cardiac surgery equipment in China is expected to grow by 13% per year from 2011 to 2018.

With this approval, the company's distribution partner, Beijing Gloryway Medical, will immediately begin selling Fore-Sight to its Chinese customers. The Fore-Sight absolute cerebral oximeter provides a highly accurate, non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation.

This article is tagged to:
Sector: Medical Devices
Geography: China, United States

Access all of our latest analysis, data and forecasts - request a trial